[1] Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update[J]. World J Urol, 2020, 38:1895-1904. [2] Tian YQ, Yang JC, Hu JJ, et al. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: systematic analysis for the global burden of disease study 2019[J]. Front Public Health, 2023, 11:1119374. doi: 10.3389/fpubh.2023.1119374. [3] Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020[J]. CA Cancer J Clin, 2020, 70:404-423. [4] Pfister C, Gravis G, Fléchon A, et al. Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER Trial[J]. J Clin Oncol, 2022, 40:2013-2022. [5] Li Z, Niu H, Qin Q, et al. lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143/FOSL2-signaling pathway in ovarian cancer[J]. Mol Ther Nucleic Acids, 2019, 17:92-101. [6] Bian Z, Jin L, Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p[J]. Sci Rep, 2016, 6:23892. doi: 10.1038/srep23892. [7] Shang C, Guo Y, Zhang J, et al. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer[J]. Cancer Chemother Pharmacol, 2016, 77:1061-1067. [8] Fang Q, Chen X, Zhi X. Long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b[J]. Med Sci Monit, 2016, 22:3506-3513. [9] Bashiri H, Tabatabaeian H. Autophagy: a potential therapeutic target to tackle drug resistance in multiple myeloma[J]. Int J Mol Sci, 2023, 24:6019. doi: 10.3390/ijms24076019. [10] Li C, Zhao Z, Zhou Z, et al. Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis[J]. Cancer Chemother Pharmacol, 2016, 78:1199-1207. [11] Hu Z, Cai M, Zhang Y, et al. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway[J]. Cell Cycle, 2020, 19:193-206. [12] Azhati B, Maolakuerban N, Ma T, et al. Up-regulation of DRAM2 promotes tolerance of bladder transitional cell carcinoma to gemcitabine[J]. Arch Med Sci, 2020, 16:1207-1217. [13] Li Z, Song Y, Hou W, et al. Atractylodin induces oxidative stress-mediated apoptosis and autophagy in human breast cancer MCF-7 cells through inhibition of the P13K/Akt/mTOR pathway[J]. J Biochem Mol Toxicol, 2022, 36:e23081. doi: 10.1002/jbt.23081. [14] Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer[J]. Mol Cancer, 2020, 19:12. doi: 10.1186/s12943-020-1138-4. |